Site Search

Share

X

Search Results

Join in asking the Colorado Legislature and Governor Polis to level the playing field on biomarker testing

Currently, not all Coloradans may benefit from the latest advancements in biomarker testing and precision medicine.  Biomarker testing is all about connecting patients to the right treatment at the right time.  Precision medicine, which uses information about a ...

Media Advisory: Advocates to Urge State Lawmakers to Pass Biomarker Testing Bill at Annual Cancer Action Day

... travel to the General Assembly on Wednesday, April 16, to meet with lawmakers and ask for their support of House Bill 567 to increase access to biomarker testing. When someone faces a cancer diagnosis, biomarker testing may help their doctors determine the right therapy or treatment. It can save patients from enduring treatments that may not work, ...

Cancer Survivors Rally for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Bill

... today, cancer survivors gathered at Buffalo’s City Hall alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on ... 1673a and reject any attempts to weaken the bill by limiting its scope. Senate Bill 1196a / Assembly Bill 1673a seeks to ensure comprehensive biomarker testing is covered by all state-regulated health plans, including Medicaid, when medically appropriate. The bill passed the Legislature ...

Governor Walz Signs Legislation to Increase Access to Innovative Testing that Can Match Patients with Most Effective Treatments

SAINT PAUL, Minn. – Today, Governor Tim Walz signed legislation that will ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. The new law will enable more Minnesotans to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...

California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments

Sacramento, Calif. – June 21, 2022 – The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. If signed into law, Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...

Surge in Breast Cancer Among Asian American, Pacific Islander Women Underscores Need for Improved Biomarker Testing Access in Hawaii

... Society Cancer Action Network’s (ACS CAN) campaign to connect patients with the right treatment at the right time through increasing access to biomarker testing in Hawaii.   Breast cancer is the most common cancer diagnosed among women in the U.S. It is also the second-leading cause of death from ... cancer mortality rates continue to decrease thanks to advances in early detection and treatment, like targeted therapies based on the results of biomarker testing. In cancer, biomarkers are often used to help determine the best treatment for a patient. Testing involves the analysis of a ...

Calls to Improve Access to Biomarker Testing in NJ Bring Together Patients, Providers & Public Health Leaders across Disease Spectrum

Key public health, patient and provider groups have come out in support of improving access to biomarker testing in New Jersey, urging lawmakers to advance and pass Assembly Bill 4163 / Senate Bill 3098 this legislative session. This fall, a broad ... Institutions & Insurance (AFI) Committee to vote in favor of A4163, which they did—unanimously—several weeks ago. Now, the New Jersey Biomarker Coalition is looking to the Assembly Appropriations and Senate Commerce Committees to take up this bill and follow the lead of their AFI ...

Patient Advocates Rally in Times Square for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Legislation

... Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to sign Senate Bill 1196a / Assembly Bill 1673a and reject any attempts to weaken the bill by limiting its scope. Biomarker testing enables physicians to match patients with personalized care and improve patient quality of life by avoiding ineffective, invasive ...

Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum

... seeks to improve New Yorkers’ access to precision medicine, requiring all state-regulated health plans, including Medicaid, to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have rallied together in support of the legislation, citing the efficacy of and praising the innovation in precision medicine.  Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. ...

Advocates Hold Cancer Action Day at State House, Urging Lawmakers to Expand Access to Biomarker Testing & Address Affordability Concerns

... voice with lawmakers by holding an annual Cancer Action Day.  Specifically, the advocates urged support of a proposal to improve access to biomarker testing (SB 120) and legislation relative to insurance cost sharing calculations (SB 17). They also asked lawmakers to protect level funding for ... Program, the Breast & Cervical Cancer Screening Program and the State Cancer Registry. Volunteers met with lawmakers to discuss the role of biomarker testing in connecting patients with the precision medicine treatments that have been proven to reduce risk of death and improve quality ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy